Zentek Ltd.
Market Cap
$66.27M
P/E Ratio
-10.27
EPS
$-0.06
Dividend Yield
0.00%
52-Week Range
$0.54 — $1.84
Volume
25.70K
Avg Volume
274.12K
Beta
0.30
P/E (TTM)
-10.27
Forward P/E
—
PEG Ratio
-4.88
P/S (TTM)
94.67
P/B (TTM)
7.18
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.61%
ROA (TTM)
-0.46%
ROIC
—
Gross Margin
-0.75%
Operating Margin
-9.28%
Net Margin
—
Debt/Equity
0.15
Current Ratio
1.00
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.33%
EPS Growth (5Y)
-1.69%
Sales Growth (3Y)
+8.96%
Sales Growth (5Y)
+34.02%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.02
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
107.31M
Float
102.46M
Free Float %
95.49%
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
CA
Exchange
NASDAQ
IPO Date
2012-04-02
Employees
24
CEO
Mohammed Jiwan
Index Membership
—
Website
https://www.zentek.com
Zentek Ltd. (ZTEK) is a healthcare company in the medical - instruments & supplies industry listed on the NASDAQ. With a market capitalization of $66.27M, a P/E ratio of -10.27, ZTEK is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ZTEK against other stocks using dozens of fundamental and technical filters.
Zentek Ltd. (ZTEK) has a trailing twelve-month (TTM) P/E ratio of -10.27. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Zentek Ltd. (ZTEK) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Zentek Ltd. (ZTEK) has a market capitalization of $66.27 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.